Filatil (filgrastim biosimilar)
/ Probiomed
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
December 16, 2022
Effectiveness of Innovator Pegfilgrastim (Neulastim®), Generic Pegfilgrastim (Linkix®) and Filgrastim for Engraftment after Auto-HSCT in an Outpatient Setting.
(TCT-ASTCT-CIBMTR 2023)
- P2 | "HL and NHL patients received a conditioning regimen with bendamustine (180mg/m 2 /day/2days) and melphalan (140mg/m 2 /1day). Time to neutrophil and platelet engraftment by treatment arm (Neulastim®, Linkix®, y filgrastim) Conclusion In patients with lymphoma and multiple myeloma receiving auto-HSCT, generic pegfilgrastim (Linkix®) produced a similar neutrophil and platelet engraftment time to patent pegfilgrastim (Neulastim®). The use of pegfilgrastim produces a faster time to neutrophil and platelet engraftment compared to filgrastim."
Clinical • Bone Marrow Transplantation • Febrile Neutropenia • Hematological Disorders • Hematological Malignancies • Lymphoma • Multiple Myeloma • Musculoskeletal Pain • Neutropenia • Non-Hodgkin’s Lymphoma • Oncology • Pain • Transplantation
April 06, 2019
Efficacy of three filgrastim-intended copies for hematopoietic stem cell mobilization in healthy adult and pediatric donors in Mexico.
(PubMed, J Clin Apher)
- "In conclusion, three FICs available in Mexico were efficacious and without immediate severe adverse effects, resulting in significant cost savings. Evaluation of immunogenicity and establishment of a pharmacovigilance program with the use of FICs is warranted."
Clinical • Journal
1 to 2
Of
2
Go to page
1